BIOL
Biolase, Inc.
BIOL
BIOL
Delisted
BIOL was delisted on the 18th of June, 2024.
16 hedge funds and large institutions have $3.39M invested in Biolase, Inc. in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$118K | |
| 2 | +$101K | |
| 3 | +$72.5K | |
| 4 |
BlackRock
New York
|
+$17.4K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.14K |
Top Sellers
| 1 | -$70K | |
| 2 | -$35K | |
| 3 | -$24K | |
| 4 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
-$21K |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$19.7K |